<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://new.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 27 Jul 2026 08:32:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://new.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Niagen Bioscience to Present at Canaccord Genuity’s 46th Annual Growth Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+to+Present+at+Canaccord+Genuity%E2%80%99s+46th+Annual+Growth+Conference/26816645.html</link>
   <description>
&lt;p&gt;    LOS ANGELES--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2F&amp;amp;esheet=54576678&amp;amp;newsitemid=20260727769836&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Bioscience%2C+Inc.&amp;amp;index=1&amp;amp;md5=15a48dc3ffc90c47ae76bb6c9d8c050e&quot; shape=&quot;rect&quot;&gt;Niagen Bioscience, Inc.&lt;/a&gt; (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Ozan Pamir, will participate in Canaccord Genuity’s 46th Annual Growth Conference, taking place from August 11 to 13, 2026, in Boston.

&lt;/p&gt;&lt;p&gt;
Mr. Fried is scheduled to participate in a fireside chat on Tuesday, August 11, at 2:00 p.m. Eastern Time (11:00 a.m. Pacific Time). To register for the Niagen Bioscience fireside chat webcast, please visit &lt;a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+to+Present+at+Canaccord+Genuity%E2%80%99s+46th+Annual+Growth+Conference/26816645.html</guid>
   <pubDate>Mon, 27 Jul 2026 08:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NAGE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02128141</category>
   	  </item>
  <item>
   <title>Niagen Bioscience to Present at Canaccord Genuity’s 46th Annual Growth Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+to+Present+at+Canaccord+Genuity%E2%80%99s+46th+Annual+Growth+Conference/26816645.html</link>
   <description>
&lt;p&gt;    LOS ANGELES--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2F&amp;amp;esheet=54576678&amp;amp;newsitemid=20260727769836&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Bioscience%2C+Inc.&amp;amp;index=1&amp;amp;md5=15a48dc3ffc90c47ae76bb6c9d8c050e&quot; shape=&quot;rect&quot;&gt;Niagen Bioscience, Inc.&lt;/a&gt; (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Ozan Pamir, will participate in Canaccord Genuity’s 46th Annual Growth Conference, taking place from August 11 to 13, 2026, in Boston.

&lt;/p&gt;&lt;p&gt;
Mr. Fried is scheduled to participate in a fireside chat on Tuesday, August 11, at 2:00 p.m. Eastern Time (11:00 a.m. Pacific Time). To register for the Niagen Bioscience fireside chat webcast, please visit &lt;a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+to+Present+at+Canaccord+Genuity%E2%80%99s+46th+Annual+Growth+Conference/26816645.html</guid>
   <pubDate>Mon, 27 Jul 2026 08:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NAGE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02128141</category>
   	  </item>
  <item>
   <title>Niagen Bioscience to Present at Canaccord Genuity’s 46th Annual Growth Conference</title>
   <link>http://www.streetinsider.com/Business+Wire/Niagen+Bioscience+to+Present+at+Canaccord+Genuity%E2%80%99s+46th+Annual+Growth+Conference/26816645.html</link>
   <description>
&lt;p&gt;    LOS ANGELES--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2F&amp;amp;esheet=54576678&amp;amp;newsitemid=20260727769836&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Bioscience%2C+Inc.&amp;amp;index=1&amp;amp;md5=15a48dc3ffc90c47ae76bb6c9d8c050e&quot; shape=&quot;rect&quot;&gt;Niagen Bioscience, Inc.&lt;/a&gt; (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Ozan Pamir, will participate in Canaccord Genuity’s 46th Annual Growth Conference, taking place from August 11 to 13, 2026, in Boston.

&lt;/p&gt;&lt;p&gt;
Mr. Fried is scheduled to participate in a fireside chat on Tuesday, August 11, at 2:00 p.m. Eastern Time (11:00 a.m. Pacific Time). To register for the Niagen Bioscience fireside chat webcast, please visit &lt;a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Niagen+Bioscience+to+Present+at+Canaccord+Genuity%E2%80%99s+46th+Annual+Growth+Conference/26816645.html</guid>
   <pubDate>Mon, 27 Jul 2026 08:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NAGE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02128141</category>
   	  </item>
  <item>
   <title>Niagen Bioscience to Present at Canaccord Genuity’s 46th Annual Growth Conference</title>
   <link>http://www.streetinsider.com/Business+Wire/Niagen+Bioscience+to+Present+at+Canaccord+Genuity%E2%80%99s+46th+Annual+Growth+Conference/26816645.html</link>
   <description>
&lt;p&gt;    LOS ANGELES--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2F&amp;amp;esheet=54576678&amp;amp;newsitemid=20260727769836&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Bioscience%2C+Inc.&amp;amp;index=1&amp;amp;md5=15a48dc3ffc90c47ae76bb6c9d8c050e&quot; shape=&quot;rect&quot;&gt;Niagen Bioscience, Inc.&lt;/a&gt; (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Ozan Pamir, will participate in Canaccord Genuity’s 46th Annual Growth Conference, taking place from August 11 to 13, 2026, in Boston.

&lt;/p&gt;&lt;p&gt;
Mr. Fried is scheduled to participate in a fireside chat on Tuesday, August 11, at 2:00 p.m. Eastern Time (11:00 a.m. Pacific Time). To register for the Niagen Bioscience fireside chat webcast, please visit &lt;a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Niagen+Bioscience+to+Present+at+Canaccord+Genuity%E2%80%99s+46th+Annual+Growth+Conference/26816645.html</guid>
   <pubDate>Mon, 27 Jul 2026 08:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NAGE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02128141</category>
   	  </item>
  <item>
   <title>Niagen Bioscience to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+to+Report+Second+Quarter+2026+Financial+Results+on+Tuesday%2C+August+4%2C+2026/26792852.html</link>
   <description>
&lt;p&gt;    LOS ANGELES--(BUSINESS WIRE)--&lt;/p&gt;
&lt;p class=&quot;bwalignl&quot;&gt;&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2F&amp;amp;esheet=54573747&amp;amp;newsitemid=20260721656223&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Bioscience%2C+Inc.&amp;amp;index=1&amp;amp;md5=7b8b30bcaabd863e8e62241a80a0e975&quot; shape=&quot;rect&quot;&gt;Niagen Bioscience, Inc.&lt;/a&gt; (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that it will hold a conference call on Tuesday, August 4, 2026, at 4:30 p.m. ET to discuss its financial results for the second quarter, which ended June 30, 2026. The financial results will be reported in a press release after the close of regular stock market trading hours on Tuesday, August 4, 2026.&lt;/p&gt;&lt;p class=&quot;bwalignl&quot;&gt;Investor Conference Call:&lt;/p&gt;&lt;p class=&quot;bwalignl&quot;&gt;A live webcast will be held on Tuesday,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+to+Report+Second+Quarter+2026+Financial+Results+on+Tuesday%2C+August+4%2C+2026/26792852.html</guid>
   <pubDate>Tue, 21 Jul 2026 08:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NAGE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02128141</category>
   	  </item>
  <item>
   <title>Niagen Bioscience to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+to+Report+Second+Quarter+2026+Financial+Results+on+Tuesday%2C+August+4%2C+2026/26792852.html</link>
   <description>
&lt;p&gt;    LOS ANGELES--(BUSINESS WIRE)--&lt;/p&gt;
&lt;p class=&quot;bwalignl&quot;&gt;&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2F&amp;amp;esheet=54573747&amp;amp;newsitemid=20260721656223&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Bioscience%2C+Inc.&amp;amp;index=1&amp;amp;md5=7b8b30bcaabd863e8e62241a80a0e975&quot; shape=&quot;rect&quot;&gt;Niagen Bioscience, Inc.&lt;/a&gt; (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that it will hold a conference call on Tuesday, August 4, 2026, at 4:30 p.m. ET to discuss its financial results for the second quarter, which ended June 30, 2026. The financial results will be reported in a press release after the close of regular stock market trading hours on Tuesday, August 4, 2026.&lt;/p&gt;&lt;p class=&quot;bwalignl&quot;&gt;Investor Conference Call:&lt;/p&gt;&lt;p class=&quot;bwalignl&quot;&gt;A live webcast will be held on Tuesday,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+to+Report+Second+Quarter+2026+Financial+Results+on+Tuesday%2C+August+4%2C+2026/26792852.html</guid>
   <pubDate>Tue, 21 Jul 2026 08:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NAGE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02128141</category>
   	  </item>
  <item>
   <title>Niagen Bioscience to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026</title>
   <link>http://www.streetinsider.com/Business+Wire/Niagen+Bioscience+to+Report+Second+Quarter+2026+Financial+Results+on+Tuesday%2C+August+4%2C+2026/26792852.html</link>
   <description>
&lt;p&gt;    LOS ANGELES--(BUSINESS WIRE)--&lt;/p&gt;
&lt;p class=&quot;bwalignl&quot;&gt;&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2F&amp;amp;esheet=54573747&amp;amp;newsitemid=20260721656223&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Bioscience%2C+Inc.&amp;amp;index=1&amp;amp;md5=7b8b30bcaabd863e8e62241a80a0e975&quot; shape=&quot;rect&quot;&gt;Niagen Bioscience, Inc.&lt;/a&gt; (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that it will hold a conference call on Tuesday, August 4, 2026, at 4:30 p.m. ET to discuss its financial results for the second quarter, which ended June 30, 2026. The financial results will be reported in a press release after the close of regular stock market trading hours on Tuesday, August 4, 2026.&lt;/p&gt;&lt;p class=&quot;bwalignl&quot;&gt;Investor Conference Call:&lt;/p&gt;&lt;p class=&quot;bwalignl&quot;&gt;A live webcast will be held on Tuesday,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Niagen+Bioscience+to+Report+Second+Quarter+2026+Financial+Results+on+Tuesday%2C+August+4%2C+2026/26792852.html</guid>
   <pubDate>Tue, 21 Jul 2026 08:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NAGE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02128141</category>
   	  </item>
  <item>
   <title>Niagen Bioscience to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026</title>
   <link>http://www.streetinsider.com/Business+Wire/Niagen+Bioscience+to+Report+Second+Quarter+2026+Financial+Results+on+Tuesday%2C+August+4%2C+2026/26792852.html</link>
   <description>
&lt;p&gt;    LOS ANGELES--(BUSINESS WIRE)--&lt;/p&gt;
&lt;p class=&quot;bwalignl&quot;&gt;&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2F&amp;amp;esheet=54573747&amp;amp;newsitemid=20260721656223&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Bioscience%2C+Inc.&amp;amp;index=1&amp;amp;md5=7b8b30bcaabd863e8e62241a80a0e975&quot; shape=&quot;rect&quot;&gt;Niagen Bioscience, Inc.&lt;/a&gt; (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that it will hold a conference call on Tuesday, August 4, 2026, at 4:30 p.m. ET to discuss its financial results for the second quarter, which ended June 30, 2026. The financial results will be reported in a press release after the close of regular stock market trading hours on Tuesday, August 4, 2026.&lt;/p&gt;&lt;p class=&quot;bwalignl&quot;&gt;Investor Conference Call:&lt;/p&gt;&lt;p class=&quot;bwalignl&quot;&gt;A live webcast will be held on Tuesday,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Niagen+Bioscience+to+Report+Second+Quarter+2026+Financial+Results+on+Tuesday%2C+August+4%2C+2026/26792852.html</guid>
   <pubDate>Tue, 21 Jul 2026 08:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NAGE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02128141</category>
   	  </item>
  <item>
   <title>Niagen Bioscience names new senior director of global research</title>
   <link>http://www.streetinsider.com/Corporate+News/Niagen+Bioscience+names+new+senior+director+of+global+research/26777153.html</link>
   <description>&lt;p&gt;Niagen Bioscience, Inc. (NASDAQ: NAGE) has appointed Abhijit Kale, Ph.D., as Senior Director of Global External Research, effective July 20, 2026. In this role, Dr. Kale will oversee the company's worldwide network of academic and clinical research collaborations and help shape its scientific research strategy.&lt;/p&gt;&lt;p&gt;Dr. Kale brings more than a decade of experience in aging biology, translational science, and external scientific partnerships. Most recently, he served as a Scientific Review Officer at Hevolution Foundation, where he evaluated more than 600 research proposals and contributed funding recommendations across a $1 billion global longevity research portfolio. He has also held scientific leadership</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Niagen+Bioscience+names+new+senior+director+of+global+research/26777153.html</guid>
   <pubDate>Thu, 16 Jul 2026 08:32:53 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NAGE</category>
   	  </item>
  <item>
   <title>Niagen Bioscience names new senior director of global research</title>
   <link>http://www.streetinsider.com/Management+Changes/Niagen+Bioscience+names+new+senior+director+of+global+research/26777153.html</link>
   <description>&lt;p&gt;Niagen Bioscience, Inc. (NASDAQ: NAGE) has appointed Abhijit Kale, Ph.D., as Senior Director of Global External Research, effective July 20, 2026. In this role, Dr. Kale will oversee the company's worldwide network of academic and clinical research collaborations and help shape its scientific research strategy.&lt;/p&gt;&lt;p&gt;Dr. Kale brings more than a decade of experience in aging biology, translational science, and external scientific partnerships. Most recently, he served as a Scientific Review Officer at Hevolution Foundation, where he evaluated more than 600 research proposals and contributed funding recommendations across a $1 billion global longevity research portfolio. He has also held scientific leadership</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Niagen+Bioscience+names+new+senior+director+of+global+research/26777153.html</guid>
   <pubDate>Thu, 16 Jul 2026 08:32:53 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NAGE</category>
   	  </item>
  <item>
   <title>Niagen Bioscience Appoints Abhijit Kale, Ph.D., as Senior Director of Global External Research</title>
   <link>http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;&lt;i&gt;Scientific leader with deep expertise in NAD+ biology, aging research, and global research partnerships to lead the Company's expanding Niagen Research Program&lt;/i&gt;&lt;/p&gt;
&lt;p&gt;    LOS ANGELES--(BUSINESS WIRE)--&lt;/p&gt;
&lt;p style=&quot;text-align:justify&quot;&gt;&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2F&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Bioscience%2C+Inc.&amp;amp;index=1&amp;amp;md5=19b354d55347321975df45d7197230b5&quot; shape=&quot;rect&quot;&gt;Niagen Bioscience, Inc.&lt;/a&gt; (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the appointment of Abhijit Kale, Ph.D., as Senior Director of Global External Research, effective July 20, 2026.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Dr. Kale will lead Niagen Bioscience's Global &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2Fpages%2Fniagenresearchprogram&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Research+Program&amp;amp;index=2&amp;amp;md5=0ff3729463975addfe2f09f28ffb9bd3&quot; shape=&quot;rect&quot;&gt;Niagen Research Program&lt;/a&gt;, overseeing the Company's worldwide network of academic and clinical research collaborations while</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</guid>
   <pubDate>Thu, 16 Jul 2026 08:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07309385</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.07880129</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19655944</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214881</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216938</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NAGE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02128141</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03307993</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20043539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21200813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36851535</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57200044</category>
   	  </item>
  <item>
   <title>Niagen Bioscience Appoints Abhijit Kale, Ph.D., as Senior Director of Global External Research</title>
   <link>http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;&lt;i&gt;Scientific leader with deep expertise in NAD+ biology, aging research, and global research partnerships to lead the Company's expanding Niagen Research Program&lt;/i&gt;&lt;/p&gt;
&lt;p&gt;    LOS ANGELES--(BUSINESS WIRE)--&lt;/p&gt;
&lt;p style=&quot;text-align:justify&quot;&gt;&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2F&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Bioscience%2C+Inc.&amp;amp;index=1&amp;amp;md5=19b354d55347321975df45d7197230b5&quot; shape=&quot;rect&quot;&gt;Niagen Bioscience, Inc.&lt;/a&gt; (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the appointment of Abhijit Kale, Ph.D., as Senior Director of Global External Research, effective July 20, 2026.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Dr. Kale will lead Niagen Bioscience's Global &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2Fpages%2Fniagenresearchprogram&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Research+Program&amp;amp;index=2&amp;amp;md5=0ff3729463975addfe2f09f28ffb9bd3&quot; shape=&quot;rect&quot;&gt;Niagen Research Program&lt;/a&gt;, overseeing the Company's worldwide network of academic and clinical research collaborations while</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</guid>
   <pubDate>Thu, 16 Jul 2026 08:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07309385</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.07880129</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19655944</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214881</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216938</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NAGE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02128141</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03307993</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20043539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21200813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36851535</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57200044</category>
   	  </item>
  <item>
   <title>Niagen Bioscience Appoints Abhijit Kale, Ph.D., as Senior Director of Global External Research</title>
   <link>http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;&lt;i&gt;Scientific leader with deep expertise in NAD+ biology, aging research, and global research partnerships to lead the Company's expanding Niagen Research Program&lt;/i&gt;&lt;/p&gt;
&lt;p&gt;    LOS ANGELES--(BUSINESS WIRE)--&lt;/p&gt;
&lt;p style=&quot;text-align:justify&quot;&gt;&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2F&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Bioscience%2C+Inc.&amp;amp;index=1&amp;amp;md5=19b354d55347321975df45d7197230b5&quot; shape=&quot;rect&quot;&gt;Niagen Bioscience, Inc.&lt;/a&gt; (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the appointment of Abhijit Kale, Ph.D., as Senior Director of Global External Research, effective July 20, 2026.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Dr. Kale will lead Niagen Bioscience's Global &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2Fpages%2Fniagenresearchprogram&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Research+Program&amp;amp;index=2&amp;amp;md5=0ff3729463975addfe2f09f28ffb9bd3&quot; shape=&quot;rect&quot;&gt;Niagen Research Program&lt;/a&gt;, overseeing the Company's worldwide network of academic and clinical research collaborations while</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</guid>
   <pubDate>Thu, 16 Jul 2026 08:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07309385</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.07880129</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19655944</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214881</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216938</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NAGE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02128141</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03307993</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20043539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21200813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36851535</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57200044</category>
   	  </item>
  <item>
   <title>Niagen Bioscience Appoints Abhijit Kale, Ph.D., as Senior Director of Global External Research</title>
   <link>http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;&lt;i&gt;Scientific leader with deep expertise in NAD+ biology, aging research, and global research partnerships to lead the Company's expanding Niagen Research Program&lt;/i&gt;&lt;/p&gt;
&lt;p&gt;    LOS ANGELES--(BUSINESS WIRE)--&lt;/p&gt;
&lt;p style=&quot;text-align:justify&quot;&gt;&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2F&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Bioscience%2C+Inc.&amp;amp;index=1&amp;amp;md5=19b354d55347321975df45d7197230b5&quot; shape=&quot;rect&quot;&gt;Niagen Bioscience, Inc.&lt;/a&gt; (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the appointment of Abhijit Kale, Ph.D., as Senior Director of Global External Research, effective July 20, 2026.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Dr. Kale will lead Niagen Bioscience's Global &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2Fpages%2Fniagenresearchprogram&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Research+Program&amp;amp;index=2&amp;amp;md5=0ff3729463975addfe2f09f28ffb9bd3&quot; shape=&quot;rect&quot;&gt;Niagen Research Program&lt;/a&gt;, overseeing the Company's worldwide network of academic and clinical research collaborations while</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</guid>
   <pubDate>Thu, 16 Jul 2026 08:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07309385</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.07880129</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19655944</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214881</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216938</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NAGE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02128141</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03307993</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20043539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21200813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36851535</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57200044</category>
   	  </item>
  <item>
   <title>Niagen Bioscience Appoints Abhijit Kale, Ph.D., as Senior Director of Global External Research</title>
   <link>http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;&lt;i&gt;Scientific leader with deep expertise in NAD+ biology, aging research, and global research partnerships to lead the Company's expanding Niagen Research Program&lt;/i&gt;&lt;/p&gt;
&lt;p&gt;    LOS ANGELES--(BUSINESS WIRE)--&lt;/p&gt;
&lt;p style=&quot;text-align:justify&quot;&gt;&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2F&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Bioscience%2C+Inc.&amp;amp;index=1&amp;amp;md5=19b354d55347321975df45d7197230b5&quot; shape=&quot;rect&quot;&gt;Niagen Bioscience, Inc.&lt;/a&gt; (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the appointment of Abhijit Kale, Ph.D., as Senior Director of Global External Research, effective July 20, 2026.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Dr. Kale will lead Niagen Bioscience's Global &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2Fpages%2Fniagenresearchprogram&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Research+Program&amp;amp;index=2&amp;amp;md5=0ff3729463975addfe2f09f28ffb9bd3&quot; shape=&quot;rect&quot;&gt;Niagen Research Program&lt;/a&gt;, overseeing the Company's worldwide network of academic and clinical research collaborations while</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</guid>
   <pubDate>Thu, 16 Jul 2026 08:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07309385</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.07880129</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19655944</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214881</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216938</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NAGE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02128141</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03307993</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20043539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21200813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36851535</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57200044</category>
   	  </item>
  <item>
   <title>Niagen Bioscience Appoints Abhijit Kale, Ph.D., as Senior Director of Global External Research</title>
   <link>http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;&lt;i&gt;Scientific leader with deep expertise in NAD+ biology, aging research, and global research partnerships to lead the Company's expanding Niagen Research Program&lt;/i&gt;&lt;/p&gt;
&lt;p&gt;    LOS ANGELES--(BUSINESS WIRE)--&lt;/p&gt;
&lt;p style=&quot;text-align:justify&quot;&gt;&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2F&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Bioscience%2C+Inc.&amp;amp;index=1&amp;amp;md5=19b354d55347321975df45d7197230b5&quot; shape=&quot;rect&quot;&gt;Niagen Bioscience, Inc.&lt;/a&gt; (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the appointment of Abhijit Kale, Ph.D., as Senior Director of Global External Research, effective July 20, 2026.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Dr. Kale will lead Niagen Bioscience's Global &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2Fpages%2Fniagenresearchprogram&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Research+Program&amp;amp;index=2&amp;amp;md5=0ff3729463975addfe2f09f28ffb9bd3&quot; shape=&quot;rect&quot;&gt;Niagen Research Program&lt;/a&gt;, overseeing the Company's worldwide network of academic and clinical research collaborations while</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</guid>
   <pubDate>Thu, 16 Jul 2026 08:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07309385</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.07880129</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19655944</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214881</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216938</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NAGE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02128141</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03307993</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20043539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21200813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36851535</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57200044</category>
   	  </item>
  <item>
   <title>Niagen Bioscience Appoints Abhijit Kale, Ph.D., as Senior Director of Global External Research</title>
   <link>http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;&lt;i&gt;Scientific leader with deep expertise in NAD+ biology, aging research, and global research partnerships to lead the Company's expanding Niagen Research Program&lt;/i&gt;&lt;/p&gt;
&lt;p&gt;    LOS ANGELES--(BUSINESS WIRE)--&lt;/p&gt;
&lt;p style=&quot;text-align:justify&quot;&gt;&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2F&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Bioscience%2C+Inc.&amp;amp;index=1&amp;amp;md5=19b354d55347321975df45d7197230b5&quot; shape=&quot;rect&quot;&gt;Niagen Bioscience, Inc.&lt;/a&gt; (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the appointment of Abhijit Kale, Ph.D., as Senior Director of Global External Research, effective July 20, 2026.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Dr. Kale will lead Niagen Bioscience's Global &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2Fpages%2Fniagenresearchprogram&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Research+Program&amp;amp;index=2&amp;amp;md5=0ff3729463975addfe2f09f28ffb9bd3&quot; shape=&quot;rect&quot;&gt;Niagen Research Program&lt;/a&gt;, overseeing the Company's worldwide network of academic and clinical research collaborations while</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</guid>
   <pubDate>Thu, 16 Jul 2026 08:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07309385</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.07880129</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19655944</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214881</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216938</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NAGE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02128141</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03307993</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20043539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21200813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36851535</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57200044</category>
   	  </item>
  <item>
   <title>Niagen Bioscience Appoints Abhijit Kale, Ph.D., as Senior Director of Global External Research</title>
   <link>http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;&lt;i&gt;Scientific leader with deep expertise in NAD+ biology, aging research, and global research partnerships to lead the Company's expanding Niagen Research Program&lt;/i&gt;&lt;/p&gt;
&lt;p&gt;    LOS ANGELES--(BUSINESS WIRE)--&lt;/p&gt;
&lt;p style=&quot;text-align:justify&quot;&gt;&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2F&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Bioscience%2C+Inc.&amp;amp;index=1&amp;amp;md5=19b354d55347321975df45d7197230b5&quot; shape=&quot;rect&quot;&gt;Niagen Bioscience, Inc.&lt;/a&gt; (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the appointment of Abhijit Kale, Ph.D., as Senior Director of Global External Research, effective July 20, 2026.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Dr. Kale will lead Niagen Bioscience's Global &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2Fpages%2Fniagenresearchprogram&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Research+Program&amp;amp;index=2&amp;amp;md5=0ff3729463975addfe2f09f28ffb9bd3&quot; shape=&quot;rect&quot;&gt;Niagen Research Program&lt;/a&gt;, overseeing the Company's worldwide network of academic and clinical research collaborations while</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</guid>
   <pubDate>Thu, 16 Jul 2026 08:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07309385</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.07880129</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19655944</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214881</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216938</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NAGE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02128141</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03307993</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20043539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21200813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36851535</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57200044</category>
   	  </item>
  <item>
   <title>Niagen Bioscience Appoints Abhijit Kale, Ph.D., as Senior Director of Global External Research</title>
   <link>http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;&lt;i&gt;Scientific leader with deep expertise in NAD+ biology, aging research, and global research partnerships to lead the Company's expanding Niagen Research Program&lt;/i&gt;&lt;/p&gt;
&lt;p&gt;    LOS ANGELES--(BUSINESS WIRE)--&lt;/p&gt;
&lt;p style=&quot;text-align:justify&quot;&gt;&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2F&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Bioscience%2C+Inc.&amp;amp;index=1&amp;amp;md5=19b354d55347321975df45d7197230b5&quot; shape=&quot;rect&quot;&gt;Niagen Bioscience, Inc.&lt;/a&gt; (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the appointment of Abhijit Kale, Ph.D., as Senior Director of Global External Research, effective July 20, 2026.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Dr. Kale will lead Niagen Bioscience's Global &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2Fpages%2Fniagenresearchprogram&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Research+Program&amp;amp;index=2&amp;amp;md5=0ff3729463975addfe2f09f28ffb9bd3&quot; shape=&quot;rect&quot;&gt;Niagen Research Program&lt;/a&gt;, overseeing the Company's worldwide network of academic and clinical research collaborations while</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</guid>
   <pubDate>Thu, 16 Jul 2026 08:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07309385</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.07880129</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19655944</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214881</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216938</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NAGE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02128141</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03307993</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20043539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21200813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36851535</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57200044</category>
   	  </item>
  <item>
   <title>Niagen Bioscience Appoints Abhijit Kale, Ph.D., as Senior Director of Global External Research</title>
   <link>http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;&lt;i&gt;Scientific leader with deep expertise in NAD+ biology, aging research, and global research partnerships to lead the Company's expanding Niagen Research Program&lt;/i&gt;&lt;/p&gt;
&lt;p&gt;    LOS ANGELES--(BUSINESS WIRE)--&lt;/p&gt;
&lt;p style=&quot;text-align:justify&quot;&gt;&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2F&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Bioscience%2C+Inc.&amp;amp;index=1&amp;amp;md5=19b354d55347321975df45d7197230b5&quot; shape=&quot;rect&quot;&gt;Niagen Bioscience, Inc.&lt;/a&gt; (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the appointment of Abhijit Kale, Ph.D., as Senior Director of Global External Research, effective July 20, 2026.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Dr. Kale will lead Niagen Bioscience's Global &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2Fpages%2Fniagenresearchprogram&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Research+Program&amp;amp;index=2&amp;amp;md5=0ff3729463975addfe2f09f28ffb9bd3&quot; shape=&quot;rect&quot;&gt;Niagen Research Program&lt;/a&gt;, overseeing the Company's worldwide network of academic and clinical research collaborations while</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</guid>
   <pubDate>Thu, 16 Jul 2026 08:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07309385</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.07880129</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19655944</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214881</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216938</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NAGE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02128141</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03307993</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20043539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21200813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36851535</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57200044</category>
   	  </item>
  <item>
   <title>Niagen Bioscience Appoints Abhijit Kale, Ph.D., as Senior Director of Global External Research</title>
   <link>http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;&lt;i&gt;Scientific leader with deep expertise in NAD+ biology, aging research, and global research partnerships to lead the Company's expanding Niagen Research Program&lt;/i&gt;&lt;/p&gt;
&lt;p&gt;    LOS ANGELES--(BUSINESS WIRE)--&lt;/p&gt;
&lt;p style=&quot;text-align:justify&quot;&gt;&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2F&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Bioscience%2C+Inc.&amp;amp;index=1&amp;amp;md5=19b354d55347321975df45d7197230b5&quot; shape=&quot;rect&quot;&gt;Niagen Bioscience, Inc.&lt;/a&gt; (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the appointment of Abhijit Kale, Ph.D., as Senior Director of Global External Research, effective July 20, 2026.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Dr. Kale will lead Niagen Bioscience's Global &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2Fpages%2Fniagenresearchprogram&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Research+Program&amp;amp;index=2&amp;amp;md5=0ff3729463975addfe2f09f28ffb9bd3&quot; shape=&quot;rect&quot;&gt;Niagen Research Program&lt;/a&gt;, overseeing the Company's worldwide network of academic and clinical research collaborations while</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</guid>
   <pubDate>Thu, 16 Jul 2026 08:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07309385</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.07880129</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19655944</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214881</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216938</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NAGE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02128141</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03307993</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20043539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21200813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36851535</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57200044</category>
   	  </item>
  <item>
   <title>Niagen Bioscience Appoints Abhijit Kale, Ph.D., as Senior Director of Global External Research</title>
   <link>http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;&lt;i&gt;Scientific leader with deep expertise in NAD+ biology, aging research, and global research partnerships to lead the Company's expanding Niagen Research Program&lt;/i&gt;&lt;/p&gt;
&lt;p&gt;    LOS ANGELES--(BUSINESS WIRE)--&lt;/p&gt;
&lt;p style=&quot;text-align:justify&quot;&gt;&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2F&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Bioscience%2C+Inc.&amp;amp;index=1&amp;amp;md5=19b354d55347321975df45d7197230b5&quot; shape=&quot;rect&quot;&gt;Niagen Bioscience, Inc.&lt;/a&gt; (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the appointment of Abhijit Kale, Ph.D., as Senior Director of Global External Research, effective July 20, 2026.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Dr. Kale will lead Niagen Bioscience's Global &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2Fpages%2Fniagenresearchprogram&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Research+Program&amp;amp;index=2&amp;amp;md5=0ff3729463975addfe2f09f28ffb9bd3&quot; shape=&quot;rect&quot;&gt;Niagen Research Program&lt;/a&gt;, overseeing the Company's worldwide network of academic and clinical research collaborations while</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</guid>
   <pubDate>Thu, 16 Jul 2026 08:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07309385</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.07880129</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19655944</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214881</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216938</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NAGE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02128141</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03307993</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20043539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21200813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36851535</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57200044</category>
   	  </item>
  <item>
   <title>Niagen Bioscience Appoints Abhijit Kale, Ph.D., as Senior Director of Global External Research</title>
   <link>http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;&lt;i&gt;Scientific leader with deep expertise in NAD+ biology, aging research, and global research partnerships to lead the Company's expanding Niagen Research Program&lt;/i&gt;&lt;/p&gt;
&lt;p&gt;    LOS ANGELES--(BUSINESS WIRE)--&lt;/p&gt;
&lt;p style=&quot;text-align:justify&quot;&gt;&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2F&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Bioscience%2C+Inc.&amp;amp;index=1&amp;amp;md5=19b354d55347321975df45d7197230b5&quot; shape=&quot;rect&quot;&gt;Niagen Bioscience, Inc.&lt;/a&gt; (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the appointment of Abhijit Kale, Ph.D., as Senior Director of Global External Research, effective July 20, 2026.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Dr. Kale will lead Niagen Bioscience's Global &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2Fpages%2Fniagenresearchprogram&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Research+Program&amp;amp;index=2&amp;amp;md5=0ff3729463975addfe2f09f28ffb9bd3&quot; shape=&quot;rect&quot;&gt;Niagen Research Program&lt;/a&gt;, overseeing the Company's worldwide network of academic and clinical research collaborations while</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</guid>
   <pubDate>Thu, 16 Jul 2026 08:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07309385</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.07880129</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19655944</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214881</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216938</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NAGE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02128141</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03307993</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20043539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21200813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36851535</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57200044</category>
   	  </item>
  <item>
   <title>Niagen Bioscience Appoints Abhijit Kale, Ph.D., as Senior Director of Global External Research</title>
   <link>http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;&lt;i&gt;Scientific leader with deep expertise in NAD+ biology, aging research, and global research partnerships to lead the Company's expanding Niagen Research Program&lt;/i&gt;&lt;/p&gt;
&lt;p&gt;    LOS ANGELES--(BUSINESS WIRE)--&lt;/p&gt;
&lt;p style=&quot;text-align:justify&quot;&gt;&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2F&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Bioscience%2C+Inc.&amp;amp;index=1&amp;amp;md5=19b354d55347321975df45d7197230b5&quot; shape=&quot;rect&quot;&gt;Niagen Bioscience, Inc.&lt;/a&gt; (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the appointment of Abhijit Kale, Ph.D., as Senior Director of Global External Research, effective July 20, 2026.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Dr. Kale will lead Niagen Bioscience's Global &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2Fpages%2Fniagenresearchprogram&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Research+Program&amp;amp;index=2&amp;amp;md5=0ff3729463975addfe2f09f28ffb9bd3&quot; shape=&quot;rect&quot;&gt;Niagen Research Program&lt;/a&gt;, overseeing the Company's worldwide network of academic and clinical research collaborations while</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</guid>
   <pubDate>Thu, 16 Jul 2026 08:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07309385</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.07880129</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19655944</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214881</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216938</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NAGE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02128141</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03307993</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20043539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21200813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36851535</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57200044</category>
   	  </item>
  <item>
   <title>Niagen Bioscience Appoints Abhijit Kale, Ph.D., as Senior Director of Global External Research</title>
   <link>http://www.streetinsider.com/Business+Wire/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;&lt;i&gt;Scientific leader with deep expertise in NAD+ biology, aging research, and global research partnerships to lead the Company's expanding Niagen Research Program&lt;/i&gt;&lt;/p&gt;
&lt;p&gt;    LOS ANGELES--(BUSINESS WIRE)--&lt;/p&gt;
&lt;p style=&quot;text-align:justify&quot;&gt;&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2F&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Bioscience%2C+Inc.&amp;amp;index=1&amp;amp;md5=19b354d55347321975df45d7197230b5&quot; shape=&quot;rect&quot;&gt;Niagen Bioscience, Inc.&lt;/a&gt; (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the appointment of Abhijit Kale, Ph.D., as Senior Director of Global External Research, effective July 20, 2026.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Dr. Kale will lead Niagen Bioscience's Global &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.niagenbioscience.com%2Fpages%2Fniagenresearchprogram&amp;amp;esheet=54571562&amp;amp;newsitemid=20260716002772&amp;amp;lan=en-US&amp;amp;anchor=Niagen+Research+Program&amp;amp;index=2&amp;amp;md5=0ff3729463975addfe2f09f28ffb9bd3&quot; shape=&quot;rect&quot;&gt;Niagen Research Program&lt;/a&gt;, overseeing the Company's worldwide network of academic and clinical research collaborations while</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Niagen+Bioscience+Appoints+Abhijit+Kale%2C+Ph.D.%2C+as+Senior+Director+of+Global+External+Research/26777146.html</guid>
   <pubDate>Thu, 16 Jul 2026 08:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.07309385</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.07880129</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16949560</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19655944</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214881</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216938</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NAGE</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02128141</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03307993</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20043539</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20831026</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21200813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36851535</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57200044</category>
   	  </item>
 </channel>
</rss>
